Immix Biopharma, Inc.
IMMX
$8.18
$0.172.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.21% | -7.64% | -21.58% | -14.78% | -40.11% |
| Total Depreciation and Amortization | 215.86% | 308.29% | 291.27% | 421.45% | 1,998.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.82% | -19.85% | -9.98% | -0.78% | 22.51% |
| Change in Net Operating Assets | -31.90% | 124.59% | 682.90% | 153.51% | 140.04% |
| Cash from Operations | -63.96% | 8.99% | 15.76% | 4.98% | -28.35% |
| Capital Expenditure | 37.77% | -57.23% | -115.92% | -166.53% | -2,160.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -512.53% | -57.23% | -115.92% | -166.53% | -2,160.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 574.19% | -28.12% | -95.84% | -100.00% | 2.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 573.33% | -29.13% | -95.83% | -100.00% | 3.14% |
| Foreign Exchange rate Adjustments | 205.56% | -118.18% | 88.89% | -105.17% | -110.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44,203.66% | -3,565.93% | -208.97% | -175.03% | -95.77% |